Skip to main content
ConductScienceScienceDex

Njar, Vincent Collins Ofuka

From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.

FY2022 NIH rank #9,929
Unclaimed recordClaim profile

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2005 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2022

Linked Award Amount
$995.1K
Full award amounts, FY2022
Award Records
1
Records listing this PI
Award-Linked Rank
#9,929
By linked amount among FY2022 PIs
Earliest Year Loaded
2005
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Njar, Vincent Collins Ofuka. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2022 award records by amount

NIH award records listing Njar, Vincent Collins Ofuka as a PI. Multi-PI records show the full award amount for context.

  • 5R44CA257495-02R44Contact PI
    Development of VNLG-152R as novel therapeutic for triple negative breast cancer
    Isoprene Pharmaceuticals, Inc.
    $995.1K
    award amount

Award organization

Organizations that administered FY2022 awards listing Njar, Vincent Collins Ofuka as a PI.

FY2022 award administered by Isoprene Pharmaceuticals, Inc. (MD).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2005
    First NIH Award
    Isoprene Pharmaceuticals, Inc.
  2. 2021
    $500K Cumulative Funding
  3. 2021
    $1M Cumulative Funding
  4. 2021
    Entered Top 50% Nationally
    Ranked #9339
  5. 2022
    $2M Cumulative Funding

Explore further

Find collaborators for Njar, Vincent Collins Ofuka

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →